Literature DB >> 8769349

Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects.

D I Phillips1, S Caddy, V Ilic, B A Fielding, K N Frayn, A C Borthwick, R Taylor.   

Abstract

Intracellular triglyceride (TG) is an important energy source for skeletal muscle. However, recent evidence suggests that if muscle contains abnormally high TG stores its sensitivity to insulin may be reduced, and this could predispose to type II diabetes. To test this hypothesis, we measured muscle lipid content in 27 women aged 47 to 55 years (mean, 52) and related it to their glucose tolerance, insulin resistance, and muscle insulin sensitivity as measured by insulin activation of glycogen synthase, an insulin-regulated enzyme that is rate-limiting for insulin action in muscle. Both muscle TG content and intracellular lipid determined by Oil red O staining of muscle fibers were negatively associated with glycogen synthase activation (r = .43, P = .03 and r = -.47, P = .02, respectively). In addition, intracellular lipid correlated with features of the insulin resistance syndrome, including an increased waist to hip ratio (r = .47, P = .01) and fasting nonesterified fatty acids ([NEFA] r = .44, P = .04). These data demonstrate that increased muscle TG stores are associated with decreased insulin-stimulated glycogen synthase activity. Intracellular fat may underlie a major part of the insulin resistance in normal subjects, as well as type II diabetics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769349     DOI: 10.1016/s0026-0495(96)90260-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  78 in total

Review 1.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance.

Authors:  David E Kelley
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 3.  The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans.

Authors:  Martin Krssak; Michael Roden
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 4.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Authors:  François R Jornayvaz; Varman T Samuel; Gerald I Shulman
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 5.  Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state.

Authors:  Luc J C van Loon; Bret H Goodpaster
Journal:  Pflugers Arch       Date:  2005-09-10       Impact factor: 3.657

Review 6.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

Review 7.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

8.  Loss of protein kinase Cbeta function protects mice against diet-induced obesity and development of hepatic steatosis and insulin resistance.

Authors:  Wei Huang; Rishipal Bansode; Madhu Mehta; Kamal D Mehta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 9.  Defect of insulin signal in peripheral tissues: Important role of ceramide.

Authors:  Rima Hage Hassan; Olivier Bourron; Eric Hajduch
Journal:  World J Diabetes       Date:  2014-06-15

10.  A clinic-based lifestyle intervention for pediatric obesity: efficacy and behavioral and biochemical predictors of response.

Authors:  Kristine A Madsen; Andrea K Garber; Michele L Mietus-Snyder; Joan K Orrell-Valente; Cam-Tu Tran; Lidya Wlasiuk; Renee I Matos; John Neuhaus; Robert H Lustig
Journal:  J Pediatr Endocrinol Metab       Date:  2009-09       Impact factor: 1.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.